National Atomic Company Kazatomprom JSC (KZAP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Dec, 2025Executive summary
Revenue for the nine months ended 30 September 2025 was Tenge 1,192,894 million, up 4.7% year-over-year, driven by a 10% increase in uranium sales volumes despite a 6% decrease in average selling price due to lower spot prices and exchange rate effects.
Net profit for the nine months was Tenge 532,915 million, down from Tenge 744,673 million in the prior year, reflecting higher costs and lower uranium prices.
Total comprehensive income for the period was Tenge 533,791 million.
Financial highlights
Gross profit for the nine months was Tenge 549,702 million, up from Tenge 446,032 million year-over-year.
Earnings per share for the nine months were Tenge 1,610, compared to Tenge 2,332 in the prior year.
Total assets as of 30 September 2025 were Tenge 3,952,965 million, with equity of Tenge 3,101,853 million.
Cash flow from operating activities for the nine months was Tenge 651,534 million, up from Tenge 483,885 million year-over-year.
Dividends paid to shareholders during the period totaled Tenge 327,858 million.
Outlook and guidance
Management expects continued volatility in uranium sales volumes due to customer delivery timing and spot price fluctuations.
The company is monitoring the impact of anti-Russian sanctions and changes in U.S. import duties, though its products remain exempt from new tariffs.
Latest events from National Atomic Company Kazatomprom JSC
- Production, sales, and realized prices increased in 1H2026 amid robust uranium market demand.KZAP
Q2 2026 TU - Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Record uranium output and resilient financials set the stage for higher 2026 growth.KZAP
Q4 2025 - Production and sales volumes increased in 2025, but realized prices declined year-over-year.KZAP
Q4 2025 TU - Revenue and profits rose on higher uranium prices, but net profit fell due to a prior one-off gain.KZAP
Q2 2025 - Production up, prices down, and 2025 guidance steady amid robust global nuclear demand.KZAP
Q2 2025 TU - Production up, sales down, new European deals, and robust dividend amid volatile uranium prices.KZAP
Q1 2025 - Net profit up 27% year-over-year; 2025 production guidance cut amid sulfuric acid constraints.KZAP
Q2 2024